Gordion
Target Discovery Scientist: Patient-Driven Genomics
Gordion, Cambridge, Massachusetts, us, 02140
Overview
By uniquely bringing
Patient Selection
into the
Target Identification
stage. Approach
Using real patients data, we integrate target identification with cohort selection into a single coherent strategy. We use 100% of Genome Data, both Exome & Dark Genome alterations. With a wealth of patient-derived tumor data, we can identify novel drug targets “invisible” in cell line-based assays. Gordion Bioscience Inc., 245 Main St, Cambridge, MA 02142, US
#J-18808-Ljbffr
By uniquely bringing
Patient Selection
into the
Target Identification
stage. Approach
Using real patients data, we integrate target identification with cohort selection into a single coherent strategy. We use 100% of Genome Data, both Exome & Dark Genome alterations. With a wealth of patient-derived tumor data, we can identify novel drug targets “invisible” in cell line-based assays. Gordion Bioscience Inc., 245 Main St, Cambridge, MA 02142, US
#J-18808-Ljbffr